Affiliation:
1. Faculty of Basic Sciences, University of Medellin, Medellin 050026, Colombia
2. Pharmacology Department, School of Biological Sciences, University of Concepcion, Concepcion 4070386, Chile
Abstract
The epidermal growth factor (EGF) is one of the most critical ligands of the EGF receptor (EGFR), a well-known oncogene frequently overexpressed in cancerous cells and an important therapeutic target in cancer. The EGF is the target of a therapeutic vaccine aimed at inducing an anti-EGF antibody response to sequester this molecule from serum. However, strikingly, very few investigations have focused on EGF immunotargeting. Since the use of nanobodies (Nbs) for EGF neutralization may be an effective therapeutic strategy in several types of cancer, in this study, we decided to generate anti-EGF Nbs from a recently constructed, phage-displaying synthetic nanobody library. To our knowledge, this is the first attempt to obtain anti-EGF Nbs from a synthetic library. By applying a selection strategy that uses four different sequential elution steps along with three rounds of selection, we obtained four different EGF-specific Nb clones, and also tested their binding capabilities as recombinant proteins. The obtained results are very encouraging and demonstrate the feasibility of selecting nanobodies against small antigens, such as the EGF, from synthetic libraries.
Funder
MINCIENCIAS, MINEDUCACIÓN, MINCIT and ICETEX
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference45 articles.
1. Human Epidermal Growth Factor: Isolation and Chemical and Biological Properties;Cohen;Proc. Natl. Acad. Sci. USA,1975
2. EGF Receptor Ligands: Recent Advances;Singh;F1000Research,2016
3. Molecular Epidemiology of Lung Cancer and Geographic Variations with Special Reference to EGFR Mutations;Mitsudomi;Transl. Lung Cancer Res.,2014
4. Human Epidermal Growth Factor in Gastric Carcinoma as a Biologic Marker of High Malignancy;Tahara;Jpn. J. Cancer Res.,1986
5. Role of Epidermal Growth Factor Receptor in Lung Cancer and Targeted Therapies;Liu;Am. J. Cancer Res.,2017